We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Protalix Protocol With Cerezyme in Short Supply
FDA Approves Protalix Protocol With Cerezyme in Short Supply
August 21, 2009
The FDA has approved the treatment protocol for Protalix BioTherapeutics to test prGCD, its experimental medicine for Gaucher’s disease, and the company plans to file an NDA by the end of the year.